Dr Deshan Sebaratnam

Clinical Associate Lecturer
Dermatology, Westmead Clinical School

C24 - Westmead Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9845 5555

Biographical details

Baulkham Hills High School: UAI 99.95

Research interests

Autoimmune bullous disease


Non-melanoma skin cancer

Quality of Life

Teaching areas

Independent Learning Activity co-supervisor

Clinical examiner (1st and 2nd year students)

Bedside tutor (3rd year students)

Clinical reasoning session facilitator (4th year students)

Personal & Professional Development Portfolio examiner

International links

United States. (University of Pennsylvania) Medical Dermatology Society Mentorship Program.


2014 | 2013 | 2012 | 2011 | 2009


  • Sebaratnam, D., Murrell, D. (2014), Dermatology training and practice in Australia. International journal of dermatology. 53(10), 1259-1264. [Abstract]
  • Sebaratnam, D., Martin, L., Venugopal, S., Mangos, G., Freiman, J., de Souza, P., Farnsworth, A., Cheung, K., Scolyer, R., Murrell, D. (2014), Diffuse melanosis cutis in the setting of BRAF(V) (600) (E) metastatic melanoma. International Journal of Dermatology. 53(11), 1409-1411. [Abstract]
  • Sebaratnam, D., Lim, A., Lowe, P., Goodman, G., Bekhor, P., Richards, S. (2014), Lasers and laser-like devices: Part two. Australasian Journal of Dermatology. 55(1), 1-14. [Abstract]


  • Sebaratnam, D., Venugopal, S., Frew, J., McMillan, J., Finkelstein, E., Martin, L., Murrell, D. (2013), Diffuse melanosis cutis: A systematic review of the literature. Journal of the American Academy of Dermatology. 68(3), 482-488. [Abstract]
  • Allahwala, U., Nadkarni, A., Sebaratnam, D. (2013), Wikipedia use amongst medical students - New insights into the digital revolution. Medical Teacher. 35(4), 337. [Abstract]
  • Sebaratnam, D., Venugopa, S., Murrell, D. (2013), Development of an excel® spreadsheet to document disease activity in autoimmune bullous disease. Acta Dermatovenerologica Croatica. , 207-208. [Abstract]
  • Tjokrowidjaja, A., Daniel, B., Frew, J., Sebaratnam, D., Hanna, A., Chee, S., Dermawan, A., Wang, C., Lim, C., Venugopal, S., Rhodes, L., Welsh, B., Nijsten, T., Murrell, D. (2013), The development and validation of the TABQOL, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease. The British Journal of Dermatology. 169(5), 1000-1006. [Abstract]
  • Sebaratnam, D., Hanna, A., Chee, S., Frew, J., Venugopal, S., Daniel, B., Martin, L., Rhodes, L., Tan, J., Wang, C., Welsh, B., Nijsten, T., Murrell, D. (2013), Development of a Quality-of-Life Instrument for Autoimmune Bullous Disease: The Autoimmune Bullous Disease Quality of Life Questionnaire. JAMA Dermatology. 149(10), 1186-1191. [Abstract]


  • Sebaratnam, D., Frew, J., Davatchi, F., Murrell, D. (2012), Quality-of-life measurement in blistering diseases. Dermatologic Clinics. 30(2), 301-307, ix. [Abstract]
  • Wang, Y., Sebaratnam, D., Wong, J., Cooper, W., Wyburn, K., Eris, J. (2012), Urethral stricture caused by schistosomiasis in a renal transplant recipient. Nephrology. , 197-198. [Abstract]
  • Sebaratnam, D., McMillan, J., Werth, V., Murrell, D. (2012), Quality of life in patients with bullous dermatoses. Clinics in Dermatology. 30(1), 103-107. [Abstract]


  • Sebaratnam, D., Murrell, D. (2011), Bullous systemic lupus erythematosus. Dermatologic Clinics. 29(4), 649-653. [Abstract]
  • Sebaratnam, D., Murrell, D. (2011), Objective scoring systems for disease activity in autoimmune bullous disease. Dermatologic Clinics. 29(3), 515-520, xi. [Abstract]
  • Sebaratnam, D., Venugopal, S., Murrell, D. (2011), A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes. Journal of the European Academy of Dermatology and Venereology. , 117-118. [Abstract]
  • Sebaratnam, D., Martin, L., Rubin, A., Tran, K., Pas, H., Marr, P., Edmonds, J., Murrell, D. (2011), Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus. Clinical and Experimental Dermatology. , 91-93. [Abstract]
  • Sebaratnam, D., Murrell, D., Werth, V. (2011), Treatment of Pemphigus. In: Evidence Based Dermatology 2nd Ed. (pp.261-275).USA: PMPH-USA, Ltd.


  • Sebaratnam, D., Murrell, D. (2009), Treatment of pemphigus vulgaris and pemphigus foliaceus. Expert Review of Dermatology. 4(5), 469-481.